{
    "title": "Individual feed for http://feeds.benzinga.com/benzinga",
    "link": "http://feeds.benzinga.com/benzinga",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-09-08T10:15:21.844593",
    "items": [
        {
            "title": "Too Good To Pass Up? Parents Want To Sell Their Home To Their Son, But The $1,500 Mortgage Might Leave Him Eating 'Ramen Every Day'",
            "link": "https://www.benzinga.com/news/25/09/47545386/too-good-to-pass-up-parents-want-to-sell-their-home-to-their-son-but-the-1500-mortgage-might-leave-him-eatin",
            "description": "read more",
            "pubDate": "2025-09-08T13:52:13",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/09/08/For-Sale-Sign.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Uber Partners With Momenta For AI-Powered Robotaxi Trials In Germany",
            "link": "https://www.benzinga.com/markets/tech/25/09/47545326/uber-partners-with-momenta-for-ai-powered-robotaxi-trials-in-germany",
            "description": "Uber and Momenta plan to test Level 4 autonomous vehicles in Munich next year, with plans to expand across Europe. read more",
            "pubDate": "2025-09-08T13:48:57",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/09/08/Uber-Says-Move-Ensures-Accessibility.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Summit Therapeutics' Lung Cancer Drug Under Dark Clouds As Keytruda Challenger Shows Regional Data Differences",
            "link": "https://www.benzinga.com/news/health-care/25/09/47544935/summit-therapeutics-lung-cancer-drug-under-dark-clouds-as-keytruda-challenger-shows-regional-dat",
            "description": "Summit's ivonescimab showed improved survival trends in NSCLC patients with favorable safety, though some results missed statistical significance thre...",
            "pubDate": "2025-09-08T13:28:07",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/09/08/Konskie--Poland---December-08--2024-Summ_0.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "How To Earn $500 A Month From Designer Brands Stock Ahead Of Q2 Earnings",
            "link": "https://www.benzinga.com/trading-ideas/dividends/25/09/47544709/how-to-earn-500-month-from-designer-brands-stock-q2-earnings",
            "description": "Designer Brands currently offers an annual dividend yield of 4.23% â€” 20 cents a year. Here's how you can earn $500 monthly. read more",
            "pubDate": "2025-09-08T13:25:27",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/09/08/Designer-Brands-Photo-by-JHVEPhoto-via-S.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        },
        {
            "title": "Jim Cramer Urges Caution On Intel Rally, Says IBM Offers More Than D-Wave",
            "link": "https://www.benzinga.com/trading-ideas/long-ideas/25/09/47544691/jim-cramer-urges-caution-on-intel-rally-says-ibm-offers-more-than-d-wave",
            "description": "Jim Cramer recommends Elbit Systems (ESLT) and Preformed Line Products (PLPC). Intel (INTC) and Gray Media (GTN) are also discussed. read more",
            "pubDate": "2025-09-08T13:22:42",
            "image_url": "https://cdn.benzinga.com/files/images/story/2025/09/08/Jim-Cramer.jpeg?optimize=medium&dpr=1&auto=webp&height=675&width=1200&fit=crop"
        }
    ]
}